鳥居薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/03/27 | 4,050 | 4,155 | 4,050 | 4,135 | +135 | +3.4% | 35,700 |
| 2024/03/26 | 3,990 | 4,035 | 3,990 | 4,000 | -10 | -0.2% | 13,700 |
| 2024/03/25 | 3,990 | 4,040 | 3,950 | 4,010 | ±0 | ±0% | 38,700 |
| 2024/03/22 | 4,075 | 4,075 | 3,995 | 4,010 | -70 | -1.7% | 44,100 |
| 2024/03/21 | 4,140 | 4,170 | 4,070 | 4,080 | -55 | -1.3% | 29,700 |
| 2024/03/19 | 4,210 | 4,210 | 4,100 | 4,135 | -75 | -1.8% | 21,300 |
| 2024/03/18 | 4,235 | 4,285 | 4,210 | 4,210 | -20 | -0.5% | 21,800 |
| 2024/03/15 | 4,245 | 4,270 | 4,215 | 4,230 | -30 | -0.7% | 16,300 |
| 2024/03/14 | 4,295 | 4,295 | 4,195 | 4,260 | -5 | -0.1% | 16,400 |
| 2024/03/13 | 4,285 | 4,290 | 4,215 | 4,265 | -15 | -0.4% | 11,300 |
| 2024/03/12 | 4,315 | 4,315 | 4,205 | 4,280 | -35 | -0.8% | 21,500 |
| 2024/03/11 | 4,300 | 4,315 | 4,255 | 4,315 | -5 | -0.1% | 21,100 |
| 2024/03/08 | 4,220 | 4,370 | 4,220 | 4,320 | +55 | +1.3% | 39,300 |
| 2024/03/07 | 4,290 | 4,310 | 4,235 | 4,265 | -10 | -0.2% | 17,500 |
| 2024/03/06 | 4,225 | 4,300 | 4,215 | 4,275 | +95 | +2.3% | 30,500 |
| 2024/03/05 | 4,160 | 4,195 | 4,080 | 4,180 | ±0 | ±0% | 22,800 |
| 2024/03/04 | 4,210 | 4,260 | 4,170 | 4,180 | -15 | -0.4% | 28,600 |
| 2024/03/01 | 4,300 | 4,305 | 4,180 | 4,195 | -65 | -1.5% | 40,500 |
| 2024/02/29 | 4,220 | 4,285 | 4,205 | 4,260 | +60 | +1.4% | 36,200 |
| 2024/02/28 | 4,300 | 4,330 | 4,200 | 4,200 | -5 | -0.1% | 60,300 |
| 2024/02/27 | 4,150 | 4,215 | 4,135 | 4,205 | +90 | +2.2% | 37,000 |
| 2024/02/26 | 4,050 | 4,130 | 4,050 | 4,115 | +95 | +2.4% | 34,400 |
| 2024/02/22 | 4,030 | 4,050 | 4,005 | 4,020 | -10 | -0.2% | 22,900 |
| 2024/02/21 | 4,040 | 4,085 | 3,995 | 4,030 | -10 | -0.2% | 31,600 |
| 2024/02/20 | 4,040 | 4,070 | 4,025 | 4,040 | +10 | +0.2% | 20,900 |
| 2024/02/19 | 4,025 | 4,040 | 3,955 | 4,030 | -40 | -1% | 37,400 |
| 2024/02/16 | 3,965 | 4,090 | 3,945 | 4,070 | +170 | +4.4% | 76,100 |
| 2024/02/15 | 3,895 | 3,900 | 3,850 | 3,900 | +5 | +0.1% | 34,300 |
| 2024/02/14 | 3,915 | 3,950 | 3,855 | 3,895 | -80 | -2% | 82,200 |
| 2024/02/13 | 3,820 | 3,980 | 3,780 | 3,975 | +360 | +10% | 134,900 |
| 2024/02/09 | 3,660 | 3,675 | 3,615 | 3,615 | -45 | -1.2% | 27,400 |
| 2024/02/08 | 3,660 | 3,690 | 3,620 | 3,660 | -15 | -0.4% | 28,800 |
| 2024/02/07 | 3,670 | 3,710 | 3,655 | 3,675 | +5 | +0.1% | 17,900 |
| 2024/02/06 | 3,700 | 3,725 | 3,670 | 3,670 | -30 | -0.8% | 30,200 |
| 2024/02/05 | 3,730 | 3,745 | 3,680 | 3,700 | -30 | -0.8% | 31,600 |
| 2024/02/02 | 3,750 | 3,755 | 3,695 | 3,730 | -20 | -0.5% | 29,600 |
| 2024/02/01 | 3,720 | 3,770 | 3,715 | 3,750 | -15 | -0.4% | 25,300 |
| 2024/01/31 | 3,700 | 3,765 | 3,685 | 3,765 | +40 | +1.1% | 35,100 |
| 2024/01/30 | 3,820 | 3,830 | 3,725 | 3,725 | -55 | -1.5% | 21,700 |
| 2024/01/29 | 3,800 | 3,820 | 3,775 | 3,780 | ±0 | ±0% | 21,000 |
| 2024/01/26 | 3,805 | 3,805 | 3,760 | 3,780 | -20 | -0.5% | 18,600 |
| 2024/01/25 | 3,760 | 3,800 | 3,760 | 3,800 | +40 | +1.1% | 32,900 |
| 2024/01/24 | 3,810 | 3,835 | 3,750 | 3,760 | -40 | -1.1% | 17,000 |
| 2024/01/23 | 3,750 | 3,825 | 3,750 | 3,800 | +55 | +1.5% | 29,600 |
| 2024/01/22 | 3,775 | 3,780 | 3,740 | 3,745 | -5 | -0.1% | 14,400 |
| 2024/01/19 | 3,690 | 3,750 | 3,690 | 3,750 | +65 | +1.8% | 17,100 |
| 2024/01/18 | 3,685 | 3,715 | 3,670 | 3,685 | ±0 | ±0% | 12,100 |
| 2024/01/17 | 3,705 | 3,750 | 3,685 | 3,685 | -20 | -0.5% | 13,000 |
| 2024/01/16 | 3,740 | 3,755 | 3,705 | 3,705 | -65 | -1.7% | 13,200 |
| 2024/01/15 | 3,725 | 3,785 | 3,700 | 3,770 | +60 | +1.6% | 17,700 |
251～
300
件表示中 / 3673件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 鳥居薬 | 435,500円 | +7.1% | -35.0% | 2.76% | 36.01倍 | 1.01倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| キッセイ薬 | 371,500円 | +14.5% | -2.3% | 2.42% | 13.59倍 | 0.72倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 東和薬品 | 253,000円 | +15.0% | -7.3% | 2.77% | 8.30倍 | 0.78倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 222,900円 | +14.2% | +41.0% | 2.06% | 10.92倍 | 1.11倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| サンバイオ | 162,700円 | - | - | 0.00% | - | 75.36倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
